摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-hydroxy-4,7-dimethoxybenzoxazin-3-one | 149182-67-2

中文名称
——
中文别名
——
英文名称
2-hydroxy-4,7-dimethoxybenzoxazin-3-one
英文别名
2-hydroxy-4,7-dimethoxy-1,4-benzoxazin-3-one;2-Hydroxy-4,7-dimethoxy-2H-1,4-benzoxazin-3(4H)-one
2-hydroxy-4,7-dimethoxybenzoxazin-3-one化学式
CAS
149182-67-2
化学式
C10H11NO5
mdl
——
分子量
225.201
InChiKey
XCSFLMDXLJMLBA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    68.2
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    2-羟基-4,7-二甲氧基-2 H -1,4-苯并恶嗪-3(4 H)-one的合成:禾本科生物活性亲电试剂的前体
    摘要:
    已经合成了2-羟基-4,7-二甲氧基-2 H -1,4-苯并恶嗪-3(4 H)-one(8),这是小麦中天然存在的迄今未描述的苯并恶嗪样缩醛糖苷的游离半缩醛糖苷。两条途径,独立。证明该环状异羟肟酸甲酯在溶液中时非常不稳定。这引起这样的假设,即从其乙缩醛葡糖苷天然释放的HDIBOA是通过甲醇盐消除而形成多中心亲电试剂的前体,该亲电试剂最近被报道是苯并恶嗪样铅的生物活性成分。
    DOI:
    10.1016/s0040-4039(96)02492-6
  • 作为产物:
    描述:
    丁布 在 palladium on activated charcoal 三氟化硼乙醚氢气potassium carbonate 作用下, 以 四氢呋喃二氯甲烷丙酮 为溶剂, 生成 2-hydroxy-4,7-dimethoxybenzoxazin-3-one
    参考文献:
    名称:
    2-羟基-4,7-二甲氧基-2 H -1,4-苯并恶嗪-3(4 H)-one的合成:禾本科生物活性亲电试剂的前体
    摘要:
    已经合成了2-羟基-4,7-二甲氧基-2 H -1,4-苯并恶嗪-3(4 H)-one(8),这是小麦中天然存在的迄今未描述的苯并恶嗪样缩醛糖苷的游离半缩醛糖苷。两条途径,独立。证明该环状异羟肟酸甲酯在溶液中时非常不稳定。这引起这样的假设,即从其乙缩醛葡糖苷天然释放的HDIBOA是通过甲醇盐消除而形成多中心亲电试剂的前体,该亲电试剂最近被报道是苯并恶嗪样铅的生物活性成分。
    DOI:
    10.1016/s0040-4039(96)02492-6
点击查看最新优质反应信息

文献信息

  • Novel compounds for use in weight loss and appetite suppression in humans
    申请人:——
    公开号:US20040192669A1
    公开(公告)日:2004-09-30
    Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, a nitrogen or another oxygen containing group, and a C 1 -C 4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.
    从单子叶植物中获得的含有苯酚分子的苯酚化合物,其中与氧含有基团,氮或另一个氧含有基团以及C1-C4烷氧基共价连接,或通过化学合成,已被发现可作为减肥剂、食欲抑制剂、情绪增强剂和关节炎、睡眠呼吸暂停、纤维肌痛、糖尿病和高血糖的辅助治疗剂。本发明的其他化学化合物可能包括苯并噁唑啉-环状羟基酰胺、内酰胺和相应的葡萄糖苷,这些化合物可能作为苯酚化合物的前体。本发明的苯酚化合物和苯酚化合物的前体,在适合人类治疗使用的浓度下,可以从单子叶植物中获得,例如在它们的早期生长状态下收获以获得最佳产量的玉米。
  • Methods for augmenting immune defenses contemplating the administration of phenolic and indoleamine-like compounds for use in animals ans humans
    申请人:——
    公开号:US20040209877A1
    公开(公告)日:2004-10-21
    Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, a nitrogen or another oxygen containing group, and a C 1 -C 4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to preserve and/or augment innate immune defenses in humans and animals. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human and animal therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.
    酚类化合物,其酚类分子上共价连接着一个含氧基团、一个氮或另一个含氧基团,以及一个 C 1 -C 4 烷氧基基团的酚类化合物,可从单子叶植物或通过化学合成获得,已被发现可保护和/或增强人类和动物的先天性免疫防御功能。本发明的其他化合物可包括苯并恶嗪环羟酸、内酰胺和相应的葡萄糖苷,它们可作为酚类化合物的前体。本发明的酚类化合物和酚类化合物前体,在适合人类和动物治疗使用的浓度下,可从单子叶植物(如玉米)中获得,这些植物处于早期生长状态,及时收获可获得最佳产量。
  • Methods for inducing anti-anxiety and calming effects in animals and humans
    申请人:Shelby J. Nancy
    公开号:US20050250772A1
    公开(公告)日:2005-11-10
    Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, a nitrogen or another oxygen containing group, and a C 1 -C 4 alkoxy group, or their precursor compounds, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to calm and/or reduce anxiety and related behaviors and states in humans and animals. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human and animal therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.
    酚类化合物,其酚类分子上共价连接着一个含氧基团、一个氮或另一个含氧基团,以及一个 C 1 -C 4 烷氧基基团的酚类化合物或其前体化合物,可从单子叶植物或通过化学合成获得,已被发现可镇静和/或减轻人类和动物的焦虑及相关行为和状态。本发明的其他化合物可包括苯并恶嗪环羟酸、内酰胺和相应的葡萄糖苷,它们可作为酚类化合物的前体。本发明的酚类化合物和酚类化合物前体,在适合人类和动物治疗使用的浓度下,可从单子叶植物(如玉米)中获得,这些植物处于早期生长状态,及时收获可获得最佳产量。
  • METHODS FOR INDUCING ANTI-ANXIETY AND CALMING EFFECTS IN ANIMALS AND HUMANS
    申请人:Seroctin Research & Technologies, Inc.
    公开号:EP1765338A1
    公开(公告)日:2007-03-28
  • US7521467B2
    申请人:——
    公开号:US7521467B2
    公开(公告)日:2009-04-21
查看更多